March 21, 2014 Genzyme, a Sanofi company, announced today that Brazil’s national health surveillance agency, ANVISA, has approved Lemtrada (alemtuzumab) for the treatment of patients …
March 21, 2014 Genzyme, a Sanofi company, announced today that Brazil’s national health surveillance agency, ANVISA, has approved Lemtrada (alemtuzumab) for the treatment of patients …